Healthy Clinical Trial
Official title:
The Association of the Levels of Blood Haemoglobin to the Distribution and Severity of Gingival Melanin Pigmentation at 3 Different Periodontal Health Status
AIM:
To evaluate the association of the levels of blood haemoglobin to the distribution and
severity of gingival melanin pigmentation at 3 different periodontal health status
SAMPLE SIZE ESTIMATION
- Done using GPower v.3.1.9.2
- Total sample size = 60 (20 each in 3 groups)
- Effect size = 40%
- Power = 80%
- α-error = 5%
SAMPLING:
- Simple random sampling
- Subjects to be recruited from out patient pool of KLE Society's Institute of Dental
Sciences, Bangalore
- Subjects to be categorised into 3 groups (20 subjects each)
1. Group A - Healthy periodontium
2. Group B - Gingivitis
3. Group C - Periodontitis
PARAMETERS ASSESSED
- Blood Haemoglobin Concentration (in %gm/dL)
- Hedin Melanin Index Score 0: No pigmentation Score 1: one or two solitary unit(s) of
pigmentation in papillary gingiva without formation of a continuous ribbon between
solitary units Score 2: More than three units of pigmentation in papillary gingiva
without the formation of a continuous ribbons of pigmentation Score 3: One or more short
continuous ribbons of pigmentation Score 4: One continuous ribbon including the entire
area between canines
STATISTICAL ANALYSIS
- SPSS for Windows Version 22.0 to be used
- Descriptive statistics: It includes expression of study parameters in terms of Mean & SD
for continuous variables, whereas in terms of frequency and proportions for categorical
variables.
- Inferential Statistics:
Chi Square Test will be used to compare the pigmentation index between 03 groups. And
similarly, gender wise comparison of hemoglobin concentration will be done using the same
test.
One-way ANOVA test followed by Tukey's HSD post hoc Analysis will be used to compare the mean
hemoglobin levels based on the pigmentation index scores in each group.
The level of significance [P-Value] was set at P<0.05
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | January 2020 |
Est. primary completion date | January 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Systemically healthy individuals - Absence of pathological gingival pigmentation 1. Group A - Healthy Periodontium: Absence of clinical signs of inflammation like bleeding on probing, erythema, edema, attachment loss, bone loss, patient symptoms, (bone levels at 1-3mm apical to CEJ) 2. Group B - Gingivitis: Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla, 3. Group C - Periodontitis: Presence of cardinal signs of inflammation along with, bleeding and discomfort on gentle probing, loss of knife-edged margin and blunting of papilla,periodontal pocketing, clinical attachment loss, radiographically assessed bone loss Exclusion Criteria: - Tobacco associated pigmentation - smoker's melanosis, chewing/ pouching tobacco - Pigmentation from exogenous pigments - amalgam tattoo, cultural tattooing, beverages, food colours, betelnut/khat chewing, heavy metals ( mercury, silver, arsenic, bismuth, graphite, lead), topical medications, other foreign bodies - Pigmentation from endogenous pigments - jaundice, ecchymosis/ petechiae, haemochromatosis, hemosiderin - Long term consumption of pigmentation causing drugs - ACTH, antimalarial drugs, busulfan, doxorubicin, minocycline, oral contraceptives, phenothiazies - Syndromes and systemic diseases associated with pigmentation - Addison's disease. Albright's syndrome, basila melanosis, ß-thalassemia, healed / healing mucocutaneous lesions, hereditary hemorrhagic Telangiectasia, HIV-associated melanosis, Neurofibromatosis, Peutz Jeghers syndrome, hamartoma, pyogenic granuloma, epulis - Benign or malignant lesions involving gingival - angiosarcoma, hemangioma, Kaposi's sarcoma, malignant melanoma, melanocytic nevus, pigmented vaculoe |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
KLE Society's Institute of Dental Sciences |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Haemoglobin to Melanin pigmentation | To assess the association of the levels of blood haemoglobin to the distribution and severity of gingival melanin pigmentation at 3 different periodontal health status by Hedin Melanin Index both by intragroup comparison within each of the 3 groups and intergroup comparison between the three groups | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |